AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene ARHGEF10L.
, go to our main page or see our latest news
Homo sapiens complex locus ARHGEF10L, encoding Rho guanine nucleotide exchange factor (GEF) 10-like.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 301 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 20 times), colon (16), eye (15), uterus (15), lung (13), synovial membrane tissue from rheumatioidarthritis (13), hippocampus (10), placenta (10), stomach (10), trachea (10), cerebellum (9), thalamus (9), amygdala (7), kidney (7), head neck (6), pancreas (6), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (5), liver and spleen (5), total brain (5), adenocarcinoma (4), ascites (4), liver (4), whole brain (4), chondrosarcoma lung metastasis cell lines (3), epidermis (3), human lung epithelial cells (3), islets of langerhans (3), nervous normal (3), retinoblastoma (3), skin (3), alveolar macrophage (2), bladder (2), bladder tumor (2), breast (2), colon, PCR rescued clones (2), colon ins (2), embryonic stem cells, cell lines H1, H7, andh9 (2), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (2), iris (2), lens (2), oligodendroglioma (2), poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors (2), prostate (2), purified pancreatic islet (2), rectum (2), spleen (2), well-differentiated endometrialadenocarcinoma, 7 pooled tumors (2), anaplastic oligodendroglioma (once), anaplastic oligodendroglioma with 1p/19qloss (once), astrocytoma grade IV, cell line (once), aveolar macrophage (once), blood, adult leukocytes (once), breast cancer (once), breast normal (once), carcinoid (once), cell lines (once), cervix (once), chondrosarcoma (once), colon tumor (once), colon tumor RER+ (once), colon tumor, RER+ (once), colonic mucosa from 3 patients with crohn'sdisease (once), colon normal (once), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (once), epidermoid carcinoma, cell line (once), esophagus (once), eye, retinoblastoma (once), fetal brain (once), hepatoblastoma (once), human placenta (once), kidney, renal cell adenocarcinoma (once), leiomios (once), leukocyte (once), liver, tumor tissue (once), lung normal (once), mammary gland (cancer tissue) (once), melanotic melanoma (once), moderately-differentiated adenocarcinoma (once), muscle (once), muscle (skeletal) (once), muscle, rhabdomyosarcoma (once), nervous tumor (once), neuroblastoma (once), ovary (once), pericardium (once), peripheral nervous system (once), pooled lung and spleen (once), primary lung cystic fibrosis epithelialcells (once), prostatic intraepithelial neoplasia - highgrade (once), renal cell adenocarcinoma (once), rhabdomyosarcoma (once), rpe/choroid (once), serous papillary carcinoma, high grade, 2pooled tumors (once), skin, normal (once), small intestine (once), testis (once), thymus (once), tongue, tumor tissue (once), trabecular meshwork (once), two pooled squamous cell carcinomas (once), uterus tumor (once).
301 cDNA clones support the 24 variants of gene ARHGEF10L
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AB046846 | | .a | 1 to 4487 | 1 to 4489 | W991R I1219V | tiling clone, available from KIAA, | | 4489/4489 (100 %) | 7 diff (99.9 %id) |
NM_018125.3 | | .a | 1 to 4500 | 1 to 4500 | W991R | RefSeq, | | 4500/4502 (99 %) | 6 diff (99.9 %id) |
DA402266 | thalamus | .a | 38 to 558 | 2 to 522 | | capped | | 521/521 (100 %) | 0 diff (100 %id) |
DB290902 | uterus | .a | 75 to 660 | 2 to 587 | | capped | | 586/586 (100 %) | 0 diff (100 %id) |
BF852712 | lung_normal | .a | 130 to 354 | 1 to 227 | | | | 227/232 (97 %) | 5 diff (97.9 %id) |
DA042438 | bladder | .a | 271 to 758 | 2 to 489 | | capped | | 488/488 (100 %) | 3 diff (99.4 %id) |
AW854568 | colon | .a | 311 to 508 | 13 to 211 | | | | 199/221 (90 %) | 13 diff (94.2 %id) |
TI_57221398 | | .a | 680 to 1436 | 65 to 820 | | | | 756/821 (92 %) | 11 diff (98.7 %id) |
BI758047 | brain | .a | 681 to 1436 | 1 to 755 | | | | 755/756 (99 %) | 6 diff (99.3 %id) |
DA325886 | hippocampus | .a | 872 to 1427 | 2 to 558 | | capped | | 557/557 (100 %) | 1 diff (99.9 %id) |
TI_1320130331 | | .a | 922 to 1681 | 804 to 45 | | | | 760/804 (94 %) | 17 diff (97.9 %id) |
DA098168 | cerebellum | .a | 948 to 1479 | 2 to 533 | | capped | | 532/532 (100 %) | 1 diff (99.9 %id) |
TI_2194578848 | | .a | 949 to 1359 | 442 to 31 | | | | 412/442 (93 %) | 0 diff (100 %id) |
TI_2194579164 | | .a | 985 to 1720 | 760 to 24 | | | | 737/765 (96 %) | 10 diff (98.7 %id) |
DB156061 | thymus | .a | 1044 to 1631 | 2 to 589 | | capped | | 588/588 (100 %) | 1 diff (99.9 %id) |
CN414851 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1045 to 1417 | 8 to 380 | | | | 373/380 (98 %) | 7 diff (98.2 %id) |
TI_2194579236 | | .a | 1138 to 1726 | 606 to 18 | | | | 589/607 (97 %) | 10 diff (98.4 %id) |
DR001368 | fetal brain | .a | 1148 to 1792 | 9 to 653 | | | | 645/653 (98 %) | 9 diff (98.7 %id) |
DA120328 | cerebellum | .a | 1171 to 1722 | 2 to 553 | | capped | | 552/552 (100 %) | 0 diff (100 %id) |
TI_1320132360 | | .a | 1180 to 1721 | 566 to 25 | | | | 542/566 (95 %) | 11 diff (98.1 %id) |
CO248451 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1238 to 1746 | 47 to 553 | | | | 507/761 (66 %) | 18 diff (97.7 %id) |
DA640048 | Liver | .a | 1254 to 1763 | 2 to 511 | | capped | | 510/510 (100 %) | 0 diff (100 %id) |
CD628990 | | .a | 1289 to 1732 | 449 to 4 | | | | 446/449 (99 %) | 0 diff (100 %id) |
BC080596 | Kidney, renal cell adenocarcinoma | .a | 1338 to 4147 | 1 to 2811 | | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 2811/2811 (100 %) | 5 diff (99.9 %id) |
TI_1320129464 | | .a | 1359 to 2396 | 170 to 1190 | | | | 1026/1068 (96 %) | 40 diff (96.3 %id) |
DA094327 | cerebellum | .a | 1360 to 1890 | 2 to 532 | | capped | | 531/531 (100 %) | 0 diff (100 %id) |
DN997640 | breast cancer, Mammary gland (cancer tissue) | .a | 1400 to 2026 | 1 to 627 | | | | 627/629 (99 %) | 6 diff (99.1 %id) |
TI_2194579242 | | .a | 1479 to 2235 | 760 to 3 | | | | 758/763 (99 %) | 2 diff (99.8 %id) |
DA385818 | thalamus | .a | 1530 to 2136 | 2 to 608 | | capped | | 607/607 (100 %) | 1 diff (99.9 %id) |
BP330815 | rectum | .a | 1569 to 2153 | 1 to 583 | | | | 583/583 (100 %) | 2 diff (99.7 %id) |
TI_1320129465 | | .a | 1585 to 2642 | 1 to 1056 | | | | 1056/1217 (86 %) | 10 diff (99.2 %id) |
CU455348 | epidermis | .a | 1610 to 2228 | 15 to 633 | | | | 619/633 (97 %) | 6 diff (99.1 %id) |
CU457088 | epidermis | .a | 1610 to 2086 | 15 to 491 | | | | 477/494 (96 %) | 12 diff (97.6 %id) |
CU455821 | epidermis | .a | 1745 to 2389 | 648 to 4 | | | Submitted on the opposite strand | 645/648 (99 %) | 2 diff (99.7 %id) |
TI_2194578855 | | .a | 1760 to 2554 | 804 to 6 | | | | 799/804 (99 %) | 8 diff (99.1 %id) |
TI_1320129466 | | .a | 1890 to 3020 | 41 to 1163 | | | | 1123/1202 (93 %) | 14 diff (98.9 %id) |
BI035847 | nervous_tumor | .a | 1916 to 2091 | 182 to 7 | | | | 176/182 (96 %) | 0 diff (100 %id) |
TI_2194578846 | | .a | 1929 to 2199 | 318 to 46 | | | | 273/318 (85 %) | 2 diff (99.4 %id) |
CD675442 | eye, lens | .a | 1942 to 2653 | 1 to 712 | | | | 712/712 (100 %) | 0 diff (100 %id) |
DA792226 | brain | .a | 1944 to 2523 | 2 to 583 | | capped | | 582/584 (99 %) | 4 diff (99.4 %id) |
DA488628 | brain | .a | 1945 to 2517 | 2 to 574 | | capped | | 573/573 (100 %) | 0 diff (100 %id) |
DB464168.
matches multiple genes | hippocampus | .a | 1981 to 2453 | 1 to 474 | | | also hits gene skukubo | 474/474 (100 %) | 7 diff (98.6 %id) |
TI_2194579240 | | .a | 1994 to 2865 | 882 to 12 | | | | 871/889 (97 %) | 8 diff (99.2 %id) |
BC115368 | PCR rescued clones | .a | 1997 to 2578 | 588 to 7 | | | Submitted on the opposite strand | 582/589 (98 %) | 1 diff (99.9 %id) |
TI_2194578853 | | .a | 2028 to 2823 | 802 to 9 | | | | 794/802 (99 %) | 1 diff (99.9 %id) |
BE780971 | eye, retinoblastoma | .a | 2061 to 2822 | 1 to 755 | | | | 755/768 (98 %) | 19 diff (97.6 %id) |
DA956076 | Spleen | .a | 2090 to 2631 | 2 to 543 | | capped | | 542/542 (100 %) | 1 diff (99.9 %id) |
AA557743 | Prostate, prostatic intraepithelial neoplasia - highgrade | .a | 2097 to 2376 | 282 to 3 | | | | 280/289 (96 %) | 0 diff (100 %id) |
TI_1320129467 | | .a | 2201 to 3348 | 15 to 1156 | | | | 1142/1255 (90 %) | 20 diff (98.5 %id) |
CA487411 | | .a | 2240 to 3129 | 1 to 889 | | tiling clone, | | 889/899 (98 %) | 10 diff (98.9 %id) |
BQ945883 | epidermoid carcinoma, cell line, lung | .a | 2251 to 3115 | 1 to 871 | | | | 871/896 (97 %) | 10 diff (98.9 %id) |
AW610051 | stomach | .a | 2348 to 2840 | 524 to 24 | | | | 501/524 (95 %) | 17 diff (96.8 %id) |
DA667701 | esophagus | .a | 2351 to 2883 | 2 to 534 | | capped | | 533/533 (100 %) | 2 diff (99.7 %id) |
TI_2194578851 | | .a | 2352 to 3264 | 917 to 7 | | | | 911/989 (92 %) | 24 diff (97.6 %id) |
Z44984 | brain, total brain | .a | 2438 to 2636 | 1 to 199 | | | | 199/199 (100 %) | 0 diff (100 %id) |
DA042689 | bladder | .a | 2448 to 2984 | 2 to 538 | | capped | | 537/537 (100 %) | 3 diff (99.5 %id) |
TI_2194579239 | | .a | 2532 to 3292 | 763 to 5 | | | | 759/763 (99 %) | 3 diff (99.7 %id) |
TI_2194579238 | | .a | 2594 to 3388 | 802 to 8 | | | | 795/802 (99 %) | 3 diff (99.7 %id) |
BM853642 | Ascites, stomach | .a | 2632 to 3068 | 1 to 438 | | | | 438/438 (100 %) | 2 diff (99.6 %id) |
Z43656 | brain, total brain | .a | 2654 to 2933 | 1 to 281 | | | | 281/281 (100 %) | 1 diff (99.7 %id) |
AA970762 | colon, colon tumor | .a | 2706 to 3125 | 1 to 420 | | | Submitted on the opposite strand | 420/420 (100 %) | 6 diff (98.6 %id) |
BE867306 | adenocarcinoma, colon | .a | 2802 to 3464 | 1 to 665 | | | | 665/1062 (62 %) | 15 diff (98.6 %id) |
BM742266 | stomach | .a | 2819 to 3348 | 1 to 529 | | | | 529/530 (99 %) | 6 diff (98.9 %id) |
BM742806 | stomach | .a | 2819 to 3431 | 1 to 609 | | | | 609/609 (100 %) | 5 diff (99.2 %id) |
BM744490 | stomach | .a | 2819 to 3455 | 1 to 637 | | | | 637/637 (100 %) | 1 diff (99.9 %id) |
BM744511 | stomach | .a | 2819 to 3405 | 1 to 588 | | | | 588/592 (99 %) | 5 diff (99.2 %id) |
BM745839 | stomach | .a | 2819 to 3341 | 1 to 523 | | | | 523/523 (100 %) | 4 diff (99.3 %id) |
BE563281 | adenocarcinoma, Pancreas | .a | 2846 to 3629 | 1 to 788 | | | | 784/854 (91 %) | 31 diff (96.4 %id) |
AI581684 | brain, oligodendroglioma | .a | 2878 to 3234 | 1 to 357 | | | Submitted on the opposite strand | 357/357 (100 %) | 1 diff (99.8 %id) |
AI460371 | brain, oligodendroglioma | .a | 2901 to 3357 | 1 to 457 | | | Submitted on the opposite strand | 457/457 (100 %) | 1 diff (99.8 %id) |
TI_2194578849 | | .a | 2917 to 3387 | 483 to 12 | | | | 472/483 (97 %) | 2 diff (99.6 %id) |
BQ306253 | breast | .a | 2965 to 3439 | 16 to 491 | | | | 476/496 (95 %) | 20 diff (96.0 %id) |
TI_2194579763 | | .a | 3021 to 4101 | 1114 to 46 | | | Submitted on the opposite strand | 1069/1261 (84 %) | 19 diff (98.5 %id) |
TI_1320129471 | | .a | 3032 to 4102 | 15 to 1084 | | | | 1070/1263 (84 %) | 16 diff (98.8 %id) |
DA837736 | placenta | .a | 3055 to 3600 | 2 to 547 | | capped | | 546/546 (100 %) | 3 diff (99.5 %id) |
BI755545 | brain | .a | 3058 to 3884 | 1 to 835 | | | | 835/835 (100 %) | 16 diff (98.1 %id) |
TI_57218703 | | .a | 3058 to 3884 | 31 to 865 | | | | 835/865 (96 %) | 20 diff (97.7 %id) |
TI_1320130297 | | .a | 3084 to 3280 | 228 to 32 | | | | 197/228 (86 %) | 3 diff (98.7 %id) |
TI_1320130315 | | .a | 3110 to 3748 | 640 to 2 | | | | 639/640 (99 %) | 11 diff (98.3 %id) |
TI_2194578856 | | .a | 3126 to 3705 | 597 to 17 | | | | 580/598 (96 %) | 37 diff (93.9 %id) |
BM717137 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3145 to 3890 | 1 to 746 | | | | 746/746 (100 %) | 4 diff (99.5 %id) |
BE161373 | head_neck | .a | 3162 to 3431 | 433 to 164 | | | Submitted on the opposite strand | 270/433 (62 %) | 0 diff (100 %id) |
CF454616 | peripheral nervous system | .a | 3174 to 3902 | 29 to 757 | | | | 729/758 (96 %) | 10 diff (98.7 %id) |
CD673128 | eye, Iris | .a | 3182 to 3686 | 1 to 505 | | | | 505/505 (100 %) | 2 diff (99.7 %id) |
BM701370 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3197 to 3560 | 1 to 364 | | | | 364/364 (100 %) | 2 diff (99.5 %id) |
T09490 | | .a | 3222 to 3465 | 36 to 279 | | | | 244/279 (87 %) | 10 diff (96.5 %id) |
H16915 | whole brain | .a | 3222 to 3683 | 38 to 506 | | | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 469/510 (91 %) | 33 diff (93.6 %id) |
BG476023 | melanotic melanoma, skin | .a | 3223 to 3905 | 1 to 708 | | | | 708/830 (85 %) | 42 diff (95.0 %id) |
T09346 | | .a | 3224 to 3504 | 42 to 324 | | | | 283/328 (86 %) | 10 diff (97.0 %id) |
BM824898 | Ascites, stomach | .a | 3360 to 3896 | 1 to 536 | | | | 536/536 (100 %) | 6 diff (98.9 %id) |
BE536052 | cervix | .a | 3383 to 3935 | 1 to 553 | | | | 553/553 (100 %) | 8 diff (98.6 %id) |
TI_59390848 | | .a | 3399 to 4129 | 98 to 832 | | | | 735/779 (94 %) | 21 diff (97.4 %id) |
BM020069 | astrocytoma grade IV, cell line, brain | .a | 3400 to 4129 | 1 to 734 | | | | 734/778 (94 %) | 21 diff (97.4 %id) |
BG698480 | skin | .a | 3411 to 3840 | 1 to 430 | | | | 430/430 (100 %) | 5 diff (98.9 %id) |
BM794205 | Ascites, stomach | .a | 3482 to 4107 | 1 to 626 | | | | 626/626 (100 %) | 9 diff (98.6 %id) |
BM727567 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3542 to 4022 | 1 to 482 | | fully sequenced, | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 482/482 (100 %) | 3 diff (99.4 %id) |
CB163888 | Liver | .a | 3576 to 4121 | 1 to 546 | | | | 546/546 (100 %) | 2 diff (99.7 %id) |
BF671784 | muscle (skeletal) | .a | 3577 to 4327 | 1 to 745 | | | | 745/999 (74 %) | 33 diff (96.7 %id) |
TI_227714047 | | .a | 3592 to 4487 | 996 to 106 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 891/998 (89 %) | 27 diff (97.3 %id) |
TI_149299113 | | .a | 3668 to 4487 | 918 to 110 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 809/916 (88 %) | 18 diff (98.1 %id) |
TI_227715199 | | .a | 3694 to 4487 | 900 to 114 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 787/973 (80 %) | 14 diff (98.6 %id) |
CD675018 | eye, lens | .a | 3720 to 4162 | 1 to 444 | | | | 444/444 (100 %) | 4 diff (99.1 %id) |
CB528729 | Aveolar Macrophage, lung | .a | 3737 to 4487 | 769 to 19 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 751/751 (100 %) | 1 diff (99.9 %id) |
CD365681 | Alveolar Macrophage, lung | .a | 3765 to 4487 | 741 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 723/723 (100 %) | 6 diff (99.2 %id) |
CN478990 | Human Lung Epithelial cells, lung | .a | 3770 to 4487 | 738 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 720/720 (100 %) | 4 diff (99.5 %id) |
CK818931 | Islets of Langerhans, Pancreas | .a | 3782 to 4241 | 1 to 461 | | | | 461/461 (100 %) | 2 diff (99.6 %id) |
BG961592 | colon | .a | 3785 to 4159 | 31 to 405 | | | | 375/405 (92 %) | 6 diff (98.6 %id) |
BM126329 | Islets of Langerhans, Pancreas | .a | 3798 to 4308 | 1 to 512 | | | | 512/512 (100 %) | 2 diff (99.7 %id) |
BF038439 | adenocarcinoma, ovary | .a | 3800 to 4488 | 1 to 682 | | | | 682/878 (77 %) | 36 diff (95.9 %id) |
CD364777 | Alveolar Macrophage, lung | .a | 3802 to 4487 | 705 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 687/687 (100 %) | 5 diff (99.3 %id) |
CA843116 | Pancreas, Purified pancreatic islet | .a | 3806 to 4185 | 1 to 381 | | fully sequenced, | | 381/381 (100 %) | 4 diff (99.0 %id) |
CA424371 | cell lines, Chondrosarcoma | .a | 3818 to 4487 | 689 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 671/671 (100 %) | 3 diff (99.6 %id) |
BM975509 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 3845 to 4487 | 662 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 644/644 (100 %) | 1 diff (99.9 %id) |
BJ995506 | hepatoblastoma | .a | 3869 to 4298 | 1 to 431 | | | | 431/431 (100 %) | 1 diff (99.8 %id) |
BU738615 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3876 to 4493 | 637 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 619/619 (100 %) | 1 diff (99.9 %id) |
BI010098 | leiomios | .a | 3943 to 4226 | 10 to 292 | | | | 283/293 (96 %) | 6 diff (98.0 %id) |
BX093888 | whole brain | .a | 3964 to 4484 | 537 to 17 | | | | 521/537 (97 %) | 0 diff (100 %id) |
AI913628 | Kidney | .a | 3965 to 4487 | 524 to 1 | | | | 524/524 (100 %) | 4 diff (99.3 %id) |
CK818930 | Islets of Langerhans, Pancreas | .a | 3982 to 4493 | 524 to 12 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 513/513 (100 %) | 2 diff (99.7 %id) |
BM681784 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 3992 to 4487 | 515 to 19 | | fully sequenced, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 497/497 (100 %) | 1 diff (99.8 %id) |
AW054875 | colon | .a | 4006 to 4488 | 483 to 1 | | | | 483/483 (100 %) | 12 diff (97.6 %id) |
AW455769 | Kidney | .a | 4024 to 4494 | 21 to 491 | | tiling clone, | | 471/499 (94 %) | 1 diff (99.8 %id) |
AI953258 | anaplastic oligodendroglioma, brain | .a | 4040 to 4470 | 432 to 1 | | | | 432/432 (100 %) | 9 diff (98.0 %id) |
BF512779 | | .a | 4047 to 4487 | 459 to 18 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 442/442 (100 %) | 1 diff (99.8 %id) |
AI680075 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 4050 to 4493 | 462 to 18 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 445/445 (100 %) | 3 diff (99.4 %id) |
AI373323 | Kidney | .a | 4060 to 4488 | 436 to 7 | | | | 430/436 (98 %) | 0 diff (100 %id) |
H16805 | whole brain | .a | 4061 to 4487 | 444 to 12 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 433/437 (99 %) | 14 diff (96.8 %id) |
AW473443 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 4061 to 4487 | 428 to 1 | | | | 428/428 (100 %) | 1 diff (99.8 %id) |
BF509344 | | .a | 4068 to 4487 | 438 to 18 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 421/421 (100 %) | 1 diff (99.8 %id) |
AW662614 | colon, moderately-differentiated adenocarcinoma | .a | 4081 to 4488 | 409 to 1 | | | | 409/409 (100 %) | 1 diff (99.8 %id) |
AA643721 | colon, colon tumor RER+ | .a | 4101 to 4488 | 397 to 9 | | | | 389/397 (97 %) | 0 diff (100 %id) |
AI651053 | Kidney | .a | 4122 to 4487 | 366 to 1 | | | | 366/366 (100 %) | 1 diff (99.8 %id) |
AI917570 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 4138 to 4488 | 352 to 1 | | | | 352/352 (100 %) | 4 diff (98.9 %id) |
AI565458 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 4138 to 4493 | 373 to 18 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 356/356 (100 %) | 1 diff (99.8 %id) |
AI698350 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 4138 to 4444 | 307 to 1 | | | | 307/307 (100 %) | 0 diff (100 %id) |
AI950680 | lung, two pooled squamous cell carcinomas | .a | 4147 to 4487 | 341 to 1 | | | | 341/341 (100 %) | 0 diff (100 %id) |
BM738742 | Ascites, stomach | .a | 4148 to 4487 | 1 to 341 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 341/341 (100 %) | 2 diff (99.5 %id) |
F02963 | brain, total brain | .a | 4152 to 4487 | 335 to 1 | | | | 335/335 (100 %) | 1 diff (99.8 %id) |
AI700400 | colon | .a | 4155 to 4445 | 292 to 2 | | | | 291/299 (97 %) | 0 diff (100 %id) |
CA843871 | Pancreas, Purified pancreatic islet | .a | 4155 to 4491 | 338 to 1 | | fully sequenced, | | 338/338 (100 %) | 5 diff (98.6 %id) |
AI697019 | colon | .a | 4161 to 4470 | 1 to 310 | | | Submitted on the opposite strand | 310/310 (100 %) | 0 diff (100 %id) |
AW007591 | colon | .a | 4163 to 4471 | 1 to 309 | | | Submitted on the opposite strand | 309/309 (100 %) | 7 diff (97.8 %id) |
AA992991 | | .a | 4165 to 4488 | 329 to 8 | | | | 322/329 (97 %) | 0 diff (100 %id) |
R93327 | liver and spleen | .a | 4166 to 4335 | 1 to 171 | | | Submitted on the opposite strand | 171/171 (100 %) | 12 diff (93.0 %id) |
AA601933 | | .a | 4174 to 4394 | 1 to 221 | | | | 221/228 (96 %) | 6 diff (97.4 %id) |
BI195977 | brain, neuroblastoma | .a | 4178 to 4487 | 1 to 313 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 313/313 (100 %) | 3 diff (99.1 %id) |
BQ326232 | colon_normal | .a | 4202 to 4488 | 1 to 293 | | | | 293/322 (90 %) | 27 diff (91.7 %id) |
CD672081 | eye, Iris | .a | 4221 to 4481 | 278 to 18 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 261/261 (100 %) | 10 diff (96.2 %id) |
CD679096 | eye, Trabecular meshwork | .a | 4224 to 4487 | 1 to 264 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 264/264 (100 %) | 0 diff (100 %id) |
AI912227 | carcinoid, lung | .a | 4236 to 4471 | 1 to 235 | | | Submitted on the opposite strand | 235/235 (100 %) | 5 diff (97.9 %id) |
BF447312 | Prostate | .a | 4256 to 4487 | 232 to 1 | | | | 232/232 (100 %) | 0 diff (100 %id) |
F03939 | brain, total brain | .a | 4308 to 4487 | 180 to 1 | | | | 180/180 (100 %) | 0 diff (100 %id) |
DB240751 | trachea | .b | 1 to 580 | 2 to 581 | | tiling clone, capped | | 580/580 (100 %) | 4 diff (99.4 %id) |
DB224366 | trachea | .b | 4 to 555 | 2 to 553 | | capped | | 552/552 (100 %) | 2 diff (99.7 %id) |
DB227790 | trachea | .b | 4 to 545 | 2 to 543 | | tiling clone, capped | | 542/542 (100 %) | 1 diff (99.9 %id) |
DB235558 | trachea | .b | 4 to 535 | 2 to 533 | | tiling clone, capped | | 532/532 (100 %) | 1 diff (99.9 %id) |
DB235577 | trachea | .b | 4 to 436 | 2 to 434 | | capped | | 433/435 (99 %) | 2 diff (99.6 %id) |
DR004832 | placenta | .b | 118 to 832 | 1 to 715 | | | | 715/715 (100 %) | 6 diff (99.2 %id) |
DA457264 | tongue, tumor tissue | .b | 140 to 701 | 2 to 563 | | capped | | 562/562 (100 %) | 1 diff (99.9 %id) |
DA629716 | Kidney | .b | 228 to 793 | 2 to 567 | | capped | | 566/566 (100 %) | 9 diff (98.5 %id) |
NM_001011722.2 | | .b | 265 to 4531 | 1 to 4267 | W952R | RefSeq, | | 4267/4269 (99 %) | 6 diff (99.9 %id) |
BC117171 | Colon, PCR rescued clones | .b | 275 to 4124 | 1 to 3850 | W952R I1180V | tiling clone, | | 3850/3850 (100 %) | 5 diff (99.9 %id) |
BC143347 | Colon, PCR rescued clones | .b | 275 to 4124 | 1 to 3850 | W952R I1180V | tiling clone, | | 3850/3850 (100 %) | 4 diff (99.9 %id) |
BX951409 | | .c | 1 to 627 | 1 to 629 | | tiling clone, | | 629/641 (98 %) | 8 diff (98.8 %id) |
DQ139833 | | .c | 196 to 4391 | 1 to 4198 | S24P W947R I1175V | tiling clone, | | 4198/4198 (100 %) | 8 diff (99.9 %id) |
TI_1320129475 | | .c | 747 to 1927 | 5 to 1196 | | | | 1192/1263 (94 %) | 27 diff (97.9 %id) |
CO246708 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 1225 to 1969 | 8 to 739 | | | | 732/828 (88 %) | 17 diff (98.0 %id) |
BG423363 | Kidney, renal cell adenocarcinoma | .c | 1258 to 1959 | 1 to 714 | | available from MGC, | | 714/903 (79 %) | 18 diff (98.1 %id) |
CO248384 | Chondrosarcoma Lung Metastasis cell lines, lung | .c | 1360 to 2060 | 47 to 745 | | | | 699/745 (93 %) | 14 diff (98.2 %id) |
BC065561 | Eye, retinoblastoma | .c | 1403 to 4391 | 1 to 2990 | | available from MGC, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 2990/2990 (100 %) | 5 diff (99.9 %id) |
BU154066 | eye, retinoblastoma | .c | 1404 to 2302 | 1 to 910 | | available from MGC, | | 910/943 (96 %) | 23 diff (97.6 %id) |
AU127232 | | .c | 1448 to 1961 | 2 to 514 | | capped | | 513/513 (100 %) | 2 diff (99.7 %id) |
CN365456 | embryonic stem cells, cell lines H1, H7, andH9 | .c | 1455 to 2146 | 1 to 694 | | | | 694/694 (100 %) | 4 diff (99.5 %id) |
DA947287 | Spleen | .c | 1688 to 2248 | 2 to 562 | | capped | | 561/561 (100 %) | 1 diff (99.9 %id) |
DA792024 | brain | .c | 1698 to 1954 | 2 to 258 | | capped | | 257/257 (100 %) | 0 diff (100 %id) |
BF527024 | anaplastic oligodendroglioma with 1p/19qloss, brain | .c | 1723 to 2459 | 1 to 741 | | | | 649/836 (77 %) | 31 diff (96.3 %id) |
DA289177 | hippocampus | .c | 1765 to 2284 | 2 to 523 | | capped, AAA | | 522/536 (97 %) | 8 diff (98.6 %id) |
AU149885 | | .c | 3880 to 4391 | 513 to 1 | | tiling clone, | | 513/587 (87 %) | 13 diff (97.8 %id) |
AK311076 | uterus | .d | 1 to 3593 | 2 to 3594 | W952R | tiling clone, | | 3594/3594 (100 %) | 8 diff (99.8 %id) |
TI_2194576687 | | .d | 52 to 1158 | 61 to 1156 | | | Submitted on the opposite strand | 1096/1231 (89 %) | 25 diff (98.0 %id) |
TI_2194579765 | | .d | 52 to 1174 | 64 to 1169 | | | Submitted on the opposite strand | 1106/1240 (89 %) | 27 diff (97.9 %id) |
TI_2194575413 | | .d | 229 to 1386 | 10 to 1163 | | | | 1154/1241 (92 %) | 13 diff (99.0 %id) |
BQ900427 | eye, retinoblastoma | .d | 314 to 802 | 8 to 496 | | | | 489/1230 (39 %) | 18 diff (98.6 %id) |
DC334731 | hippocampus | .d | 441 to 952 | 1 to 512 | | | | 512/512 (100 %) | 0 diff (100 %id) |
DC416349 | trachea | .d | 475 to 1040 | 1 to 568 | | | | 568/568 (100 %) | 3 diff (99.5 %id) |
CD628991 | | .d | 576 to 1170 | 1 to 596 | | | | 596/605 (98 %) | 14 diff (97.7 %id) |
BG951505 | colon | .d | 587 to 861 | 272 to 3 | | | | 270/275 (98 %) | 1 diff (99.7 %id) |
BP421924 | small intestine | .d | 636 to 1149 | 1 to 513 | | | Submitted on the opposite strand | 513/513 (100 %) | 1 diff (99.9 %id) |
BX100887 | liver and spleen | .d | 3251 to 3947 | 1 to 696 | | tiling clone, | | 696/696 (100 %) | 1 diff (99.9 %id) |
T86808 | liver and spleen | .d | 3251 to 3716 | 1 to 478 | | | | 478/482 (99 %) | 20 diff (95.9 %id) |
BF196924 | pooled | .d | 3843 to 4404 | 562 to 1 | | tiling clone, | | 562/562 (100 %) | 3 diff (99.5 %id) |
AW135554 | | .d | 4044 to 4405 | 379 to 18 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 362/362 (100 %) | 0 diff (100 %id) |
T86712 | liver and spleen | .d | 4119 to 4400 | 280 to 1 | | | | 280/290 (96 %) | 4 diff (98.7 %id) |
AK126877 | amygdala | .e | 1 to 4584 | 2 to 4586 | S188P W752R I980V | tiling clone, available from FLJ, | | 4586/4586 (100 %) | 8 diff (99.9 %id) |
DA192247 | amygdala | .e | 1 to 595 | 2 to 597 | | capped | | 596/596 (100 %) | 3 diff (99.5 %id) |
DB303409 | amygdala | .e | 4049 to 4584 | 537 to 1 | | tiling clone, | | 537/537 (100 %) | 1 diff (99.9 %id) |
AK092020 | | .f | 1 to 3471 | 5 to 3476 | R634* | tiling clone, available from FLJ, | | 3476/3476 (100 %) | 4 diff (99.9 %id) |
AX747316 | | .f | 1 to 3471 | 5 to 3476 | R634* | | | 3476/3476 (100 %) | 4 diff (99.9 %id) |
DA649521 | | .f | 1 to 533 | 5 to 538 | | capped | | 537/537 (100 %) | 1 diff (99.9 %id) |
DA661781 | | .f | 1 to 330 | 5 to 334 | | capped | | 333/333 (100 %) | 0 diff (100 %id) |
DA990397 | synovial membrane tissue from rheumatioidarthritis | .f | 25 to 549 | 2 to 526 | | capped | | 525/525 (100 %) | 0 diff (100 %id) |
DA994641 | synovial membrane tissue from rheumatioidarthritis | .f | 25 to 558 | 2 to 536 | | capped | | 535/535 (100 %) | 1 diff (99.9 %id) |
CB960344 | Human Placenta, placenta | .f | 31 to 515 | 28 to 523 | | | | 496/801 (61 %) | 17 diff (97.9 %id) |
DA654358 | | .f | 32 to 571 | 2 to 541 | | capped | | 540/540 (100 %) | 1 diff (99.9 %id) |
DA992631 | synovial membrane tissue from rheumatioidarthritis | .f | 32 to 568 | 2 to 539 | | capped | | 538/544 (98 %) | 3 diff (99.5 %id) |
DB221928 | trachea | .f | 35 to 572 | 2 to 539 | | capped | | 538/538 (100 %) | 1 diff (99.9 %id) |
DB061224 | testis | .f | 59 to 512 | 2 to 455 | | capped | | 454/454 (100 %) | 0 diff (100 %id) |
DA862120 | placenta | .f | 65 to 572 | 2 to 509 | | capped | | 508/508 (100 %) | 0 diff (100 %id) |
DB284544 | uterus | .f | 65 to 540 | 2 to 477 | | capped | | 476/476 (100 %) | 1 diff (99.8 %id) |
DB321651 | | .f | 2930 to 3471 | 543 to 1 | | tiling clone, | | 543/543 (100 %) | 2 diff (99.7 %id) |
DC380433 | placenta | .g | 1 to 558 | 1 to 558 | | tiling clone, | | 558/558 (100 %) | 0 diff (100 %id) |
DC426451 | placenta | .g | 1859 to 2428 | 571 to 1 | | tiling clone, | | 571/571 (100 %) | 1 diff (99.9 %id) |
DC307641 | cerebellum | .h | 1 to 552 | 1 to 552 | | tiling clone, | | 552/552 (100 %) | 0 diff (100 %id) |
DC317581 | amygdala | .h | 6 to 525 | 1 to 521 | | | | 521/521 (100 %) | 2 diff (99.7 %id) |
CN365458 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .h | 476 to 1118 | 1 to 642 | | tiling clone, | | 642/642 (100 %) | 7 diff (99.0 %id) |
AK001383 | | .h | 964 to 3982 | 1 to 3019 | | tiling clone, available from FLJ, | | 3019/3019 (100 %) | 7 diff (99.8 %id) |
DA777613 | brain | .i | 1 to 580 | 2 to 582 | | tiling clone, capped | | 581/581 (100 %) | 2 diff (99.7 %id) |
CA394245 | eye, RPE/choroid | .i | 275 to 756 | 1 to 482 | | tiling clone, | | 482/482 (100 %) | 0 diff (100 %id) |
DB326067 | brain | .i | 2113 to 2666 | 555 to 1 | | tiling clone, | | 555/555 (100 %) | 1 diff (99.9 %id) |
DA754315 | | .j | 1 to 471 | 2 to 473 | | tiling clone, capped | | 472/472 (100 %) | 2 diff (99.6 %id) |
AK300174 | placenta | .j | 48 to 2054 | 1 to 2007 | | tiling clone, | | 2007/2007 (100 %) | 0 diff (100 %id) |
BM549808 | leukocyte | .k | 1 to 794 | 16 to 819 | | tiling clone, | | 804/1107 (72 %) | 21 diff (98.2 %id) |
BC111058 | Blood, adult leukocytes | .k | 5 to 4924 | 1 to 4920 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 4920/4920 (100 %) | 3 diff (100.0 %id) |
CV385337 | breast_normal | .k | 75 to 462 | 413 to 28 | | | Submitted on the opposite strand | 386/413 (93 %) | 0 diff (100 %id) |
CN365457 | embryonic stem cells, cell lines H1, H7, andH9 | .k | 1555 to 2022 | 1 to 468 | | | | 468/468 (100 %) | 0 diff (100 %id) |
DA124571 | cerebellum | .k | 1623 to 2156 | 2 to 535 | | capped | | 534/534 (100 %) | 0 diff (100 %id) |
CV397097 | nervous_normal | .l | 1 to 371 | 383 to -3 | | | Submitted on the opposite strand | 379/383 (98 %) | 0 diff (100 %id) |
DA104651 | cerebellum | .l | 1 to 554 | 2 to 555 | | tiling clone, capped | | 554/554 (100 %) | 3 diff (99.5 %id) |
AA350680 | brain | .l | 203 to 470 | 1 to 271 | | | | 271/274 (98 %) | 6 diff (97.9 %id) |
AW953279 | | .l | 203 to 807 | 11 to 615 | | tiling clone, | | 605/615 (98 %) | 6 diff (99.1 %id) |
F06121.
matches multiple genes | brain, total brain | .l | 203 to 483 | 1 to 281 | | | also hits gene MYH10 | 281/281 (100 %) | 3 diff (99.0 %id) |
H09408 | whole brain | .l | 217 to 731 | 1 to 531 | | | | 531/537 (98 %) | 29 diff (94.6 %id) |
BG977548 | colon_ins | .l | 314 to 742 | 437 to 11 | | tiling clone, | | 427/437 (97 %) | 0 diff (100 %id) |
DA093213 | cerebellum | .l | 394 to 853 | 2 to 461 | | tiling clone, capped | | 460/460 (100 %) | 3 diff (99.4 %id) |
AA682440 | liver and spleen | .l | 739 to 1216 | 504 to 28 | | tiling clone, AAA | | 477/493 (96 %) | 0 diff (100 %id) |
BF917153 | uterus_tumor | .l | 873 to 1339 | 18 to 484 | | tiling clone, | | 467/484 (96 %) | 6 diff (98.8 %id) |
BI766539 | pooled lung and spleen | .l | 900 to 1518 | 1 to 618 | | | | 618/618 (100 %) | 13 diff (97.9 %id) |
TI_57177496 | | .l | 902 to 1518 | 35 to 650 | | | | 616/650 (94 %) | 6 diff (99.1 %id) |
BF736633 | bladder_tumor | .l | 948 to 1226 | 25 to 302 | | | | 278/302 (92 %) | 6 diff (98.1 %id) |
AK123471 | thalamus | .l | 1281 to 3541 | 1 to 2262 | Y4H I243V | tiling clone, available from FLJ, | | 2262/2262 (100 %) | 6 diff (99.8 %id) |
DA372132 | thalamus | .l | 1282 to 1830 | 2 to 551 | | capped | | 550/550 (100 %) | 2 diff (99.7 %id) |
BX485676 | | .l | 1543 to 2117 | 1 to 575 | | tiling clone, | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 575/575 (100 %) | 3 diff (99.5 %id) |
AW861173 | colon | .l | 1545 to 2056 | 1 to 511 | | | | 511/511 (100 %) | 13 diff (97.5 %id) |
AW856895 | colon | .l | 1555 to 2054 | 1 to 501 | | | | 501/501 (100 %) | 6 diff (98.9 %id) |
BX485677 | | .l | 3015 to 3535 | 539 to 19 | | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 521/521 (100 %) | 2 diff (99.7 %id) |
DB310942 | thalamus | .l | 3026 to 3541 | 517 to 1 | | tiling clone, | | 517/517 (100 %) | 1 diff (99.9 %id) |
DA468685 | | .m | 1 to 541 | 8 to 548 | | capped | | 547/547 (100 %) | 0 diff (100 %id) |
DA995922 | synovial membrane tissue from rheumatioidarthritis | .m | 1 to 531 | 8 to 541 | | capped | | 540/540 (100 %) | 3 diff (99.5 %id) |
DA619911 | | .m | 1 to 596 | 7 to 602 | | tiling clone, capped | | 601/601 (100 %) | 0 diff (100 %id) |
DA332687 | hippocampus | .m | 1 to 512 | 5 to 516 | | capped | | 515/515 (100 %) | 0 diff (100 %id) |
DB275861 | uterus | .m | 1 to 574 | 5 to 578 | | capped | | 577/577 (100 %) | 1 diff (99.9 %id) |
DB286566 | uterus | .m | 1 to 545 | 5 to 549 | | capped | | 548/548 (100 %) | 2 diff (99.7 %id) |
DA246808 | brain | .m | 1 to 588 | 2 to 589 | | capped | | 588/588 (100 %) | 1 diff (99.9 %id) |
DA992143 | synovial membrane tissue from rheumatioidarthritis | .m | 1 to 498 | 2 to 499 | | capped | | 498/498 (100 %) | 0 diff (100 %id) |
DA863746 | placenta | .m | 17 to 593 | 2 to 579 | | capped | | 578/578 (100 %) | 1 diff (99.9 %id) |
DA995613 | synovial membrane tissue from rheumatioidarthritis | .m | 25 to 596 | 2 to 573 | | capped | | 572/572 (100 %) | 0 diff (100 %id) |
DA990516 | synovial membrane tissue from rheumatioidarthritis | .m | 27 to 595 | 2 to 572 | | capped | | 571/571 (100 %) | 2 diff (99.7 %id) |
DC381331 | placenta | .m | 31 to 627 | 1 to 597 | | | | 597/597 (100 %) | 0 diff (100 %id) |
DA660338 | | .m | 32 to 588 | 2 to 558 | | capped | | 557/557 (100 %) | 0 diff (100 %id) |
DA976052 | synovial membrane tissue from rheumatioidarthritis | .m | 32 to 590 | 2 to 560 | | capped | | 559/559 (100 %) | 0 diff (100 %id) |
DA995002 | synovial membrane tissue from rheumatioidarthritis | .m | 38 to 586 | 2 to 550 | | capped | | 549/549 (100 %) | 0 diff (100 %id) |
DC318312 | amygdala | .m | 47 to 632 | 1 to 586 | | | | 586/586 (100 %) | 0 diff (100 %id) |
DA991988 | synovial membrane tissue from rheumatioidarthritis | .m | 48 to 597 | 2 to 551 | | capped | | 550/550 (100 %) | 0 diff (100 %id) |
DB276554 | uterus | .m | 48 to 590 | 2 to 544 | | capped | | 543/543 (100 %) | 0 diff (100 %id) |
DB283460 | uterus | .m | 48 to 592 | 2 to 546 | | capped | | 545/545 (100 %) | 0 diff (100 %id) |
DC349116 | | .m | 56 to 605 | 1 to 550 | | | | 550/550 (100 %) | 3 diff (99.5 %id) |
DC428644 | | .m | 59 to 632 | 1 to 574 | | | | 574/574 (100 %) | 0 diff (100 %id) |
DC295948 | synovial membrane tissue from rheumatioidarthritis | .m | 59 to 605 | 1 to 547 | | | | 547/547 (100 %) | 0 diff (100 %id) |
DC318208 | amygdala | .m | 64 to 669 | 1 to 606 | | tiling clone, | | 606/606 (100 %) | 0 diff (100 %id) |
DC334974 | hippocampus | .m | 65 to 622 | 1 to 558 | | | | 558/558 (100 %) | 0 diff (100 %id) |
DC296624 | synovial membrane tissue from rheumatioidarthritis | .m | 94 to 641 | 1 to 548 | | | | 548/548 (100 %) | 0 diff (100 %id) |
DC296584 | synovial membrane tissue from rheumatioidarthritis | .m | 95 to 669 | 1 to 575 | | | | 575/575 (100 %) | 0 diff (100 %id) |
DC422247 | uterus | .m | 95 to 669 | 1 to 573 | | | | 573/573 (100 %) | 2 diff (99.7 %id) |
DA642441 | Liver | .n | 1 to 631 | 2 to 632 | exact | tiling clone, capped | | 631/631 (100 %) | 0 diff (100 %id) |
DA182382 | amygdala | .n | 14 to 521 | 2 to 509 | | capped | | 508/508 (100 %) | 0 diff (100 %id) |
DA385807 | thalamus | .n | 14 to 511 | 2 to 500 | | capped | | 499/499 (100 %) | 1 diff (99.8 %id) |
DA095024 | cerebellum | .n | 38 to 573 | 2 to 537 | | capped | | 536/536 (100 %) | 2 diff (99.7 %id) |
DC423513 | uterus | .o | 1 to 545 | 1 to 545 | exact | tiling clone, | | 545/545 (100 %) | 0 diff (100 %id) |
AK129959 | Kidney | .p | 1 to 2778 | 1 to 2780 | R32W | tiling clone, available from FLJ, | | 2780/2780 (100 %) | 12 diff (99.6 %id) |
DA381786 | thalamus | .p | 733 to 1298 | 2 to 566 | | capped | | 565/565 (100 %) | 2 diff (99.7 %id) |
DB311458 | thalamus | .p | 2107 to 2627 | 522 to 1 | | | | 522/522 (100 %) | 3 diff (99.5 %id) |
AI986388 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .p | 2150 to 2628 | 479 to 1 | | | | 479/479 (100 %) | 3 diff (99.4 %id) |
CA310695 | Human Lung Epithelial cells, lung | .p | 2183 to 2643 | 461 to 1 | | | | 461/461 (100 %) | 2 diff (99.6 %id) |
DB284284 | uterus | .q | 1 to 536 | 2 to 537 | | tiling clone, capped | | 536/536 (100 %) | 0 diff (100 %id) |
BF002440 | colon, colon tumor, RER+ | .q | 522 to 1060 | 543 to 5 | | tiling clone, | | 539/543 (99 %) | 0 diff (100 %id) |
BX496802 | Liver | .r | 1 to 549 | 1 to 551 | | tiling clone, | | 551/551 (100 %) | 7 diff (98.8 %id) |
DA392828 | thalamus | .r | 423 to 1011 | 2 to 590 | | tiling clone, capped | | 589/589 (100 %) | 0 diff (100 %id) |
AW896965 | nervous_normal | .r | 944 to 1200 | 256 to 2 | | tiling clone, | | 255/256 (99 %) | 0 diff (100 %id) |
AW897127 | nervous_normal | .r | 944 to 1176 | 243 to 12 | | tiling clone, | | 232/243 (95 %) | 0 diff (100 %id) |
BC029928 | Skin, normal | .s-u | 1 to 1068 | 1 to 1068 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 1068/1068 (100 %) | 0 diff (100 %id) |
BG739933 | skin | .s-u | 2 to 863 | 1 to 866 | N56K K57Q V58G S59E W60L ... | available from MGC, | | 866/952 (90 %) | 41 diff (95.7 %id) |
BF744887 | breast | .s-u | 389 to 640 | 1 to 268 | | | | 268/289 (92 %) | 19 diff (93.5 %id) |
DA826557 | pericardium | .t | 1 to 573 | 2 to 574 | exact | tiling clone, capped | | 573/573 (100 %) | 0 diff (100 %id) |
BY797845 | eye | .u-u | 1 to 585 | 1 to 585 | exact | tiling clone, | | 585/585 (100 %) | 0 diff (100 %id) |
AK129606 | rectum | .va-u | 1 to 1092 | 1 to 1092 | exact | tiling clone, available from FLJ, | | 1092/1092 (100 %) | 11 diff (99.0 %id) |
DB188604 | liver, tumor tissue | .vb-u | 1 to 564 | 2 to 565 | exact | tiling clone, capped | | 564/564 (100 %) | 2 diff (99.7 %id) |
TI_1320129473 | | .vc | 1 to 511 | 1 to 511 | I64V | tiling clone, | | 511/1152 (44 %) | 5 diff (99.6 %id) |
AK300264 | placenta | Gene ARHGEF10L, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
TI_2194576306 | | Gene ARHGEF10L, variant not shown | | | | | Submitted on the opposite strand | | |
BF353675 | head_neck | Gene ARHGEF10L, variant not shown | | | | | | | |
BF810746 | colon_ins | Gene ARHGEF10L, variant not shown | | | | | Submitted on the opposite strand | | |
BG946488 | bladder_tumor | Gene ARHGEF10L, variant not shown | | | | | | | |
DA122654 | cerebellum | Gene ARHGEF10L, variant not shown | | | | capped | This clone was ignored | | |
CN267886 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | Gene ARHGEF10L, variant not shown | | | | | This clone was ignored | | |
CV390736 | head_neck | Gene ARHGEF10L, variant not shown | | | | | | | |
CV390753 | head_neck | Gene ARHGEF10L, variant not shown | | | | | | | |
CV390806 | head_neck | Gene ARHGEF10L, variant not shown | | | | | Submitted on the opposite strand | | |
CV390854 | head_neck | Gene ARHGEF10L, variant not shown | | | | | | | |
DB462777.
matches multiple genes | hippocampus | Gene ARHGEF10L, variant not shown | | | | | This clone was ignored, also hits gene skukubo | | |
DB462777.
matches multiple genes | hippocampus | Gene skukubo, variant not shown | | | | | This clone was ignored, also hits gene skukubo | | |
DB528254.
matches multiple genes | hippocampus | Gene ARHGEF10L, variant not shown | | | | | This clone was ignored, also hits gene skukubo | | |
DB528254.
matches multiple genes | hippocampus | Gene skukubo, variant not shown | | | | | This clone was ignored, also hits gene skukubo | | |
BC003073 | Muscle, rhabdomyosarcoma | Gene ARHGEF10L, variant not shown | | | | available from MGC, AAA | Suspected internal deletion, this clone was ignored | | |
BE019300 | muscle, rhabdomyosarcoma | Gene ARHGEF10L, variant not shown | | | | available from MGC, | Suspected internal deletion, this clone was ignored | | |
BE872181 | adenocarcinoma, colon | Gene ARHGEF10L, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
DB213646 | trachea | Gene ARHGEF10L, variant not shown | | | | capped | | | |
DB348907 | trachea | Gene ARHGEF10L, variant not shown | | | | | | | |
DB240903 | trachea | Gene ARHGEF10L, variant not shown | | | | capped | Suspected internal deletion, this clone was ignored | | |
BU608323 | Human Lung Epithelial cells, lung | Gene ARHGEF10L, variant not shown | | | | AAA | Suspected internal deletion, this clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t, .u-u, .va-u, .vb-u, .vc |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes DCI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !